Line 31: | Line 31: | ||
<ul> | <ul> | ||
<li>We have successfully cloned 5 of our parts to pSB1C3 backbone in order to submit to the registry; and 3 of them to pSB1A3 backbone for our biochemical assays.</li> | <li>We have successfully cloned 5 of our parts to pSB1C3 backbone in order to submit to the registry; and 3 of them to pSB1A3 backbone for our biochemical assays.</li> | ||
− | <li>We have confirmed that our | + | <li>We have confirmed that our insertions and transformations were correct through PCR check.</li> |
− | <li>We’ve conducted biochemical | + | <li>We’ve conducted a biochemical assay in which we verified our hypothesis and proved the improving effects of our genes.</li> |
</ul> | </ul> | ||
</p> | </p> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<h3>Clonings:</h3> | <h3>Clonings:</h3> | ||
<p> | <p> | ||
− | In our project, our aim was to increase the tolerance and resistance of KO11, ethanologenic strain of E.coli, to byproducts and inhibitors that occur | + | In our project, our aim was to increase the tolerance and resistance of KO11, ethanologenic strain of E.coli, to byproducts and inhibitors that occur during |
− | + | bioethanol production, specifically during the pretreatment of lignocellulosic biomass. In order to achieve that, we picked our genes of interest as FucO and GSH. | |
</p> | </p> | ||
<p> | <p> | ||
− | We’ve designed 5 parts, 2 of which are basic and 3 are composite. | + | We’ve designed 5 parts, 2 of which are basic and 3 are composite. |
</p> | </p> | ||
<p> | <p> | ||
− | One of our basic parts included only FucO and the other only GSH as the protein coding region | + | One of our basic parts included only FucO and the other only GSH as the protein coding region; and our composite parts were designed to include GSH and FucO |
− | + | separately and simultaneously. | |
</p> | </p> | ||
<p> | <p> | ||
− | As a part of our lab journey, we’ve done 8 clonings in total. 5 of them were to be submitted in the registry and 3 of them were | + | As a part of our lab journey, we’ve done 8 clonings in total. 5 of them were to be submitted in the registry and 3 of them were for our biochemical assays. |
− | + | ||
</p> | </p> | ||
<p> | <p> | ||
− | + | In order to be able to submit our parts to the registry, we inserted all of our parts to pSB1C3 backbone and cloned them to DH5α. | |
</p> | </p> | ||
Line 76: | Line 65: | ||
<p> | <p> | ||
− | In order to be able to grow colonies of DH5α with our first and second basic parts, we’ve ligated them to pSB1C3 backbone with a ratio of 1:3. Then, we’ve transformed the ligations to DH5α competent cells and grew colonies on LB agar plates containing chloramphenicol at a final concentration of 40 µg/ml. After obtaining DH5α colonies, we’ve done colony PCR and considered the results | + | In order to be able to grow colonies of DH5α with our first and second basic parts, we’ve ligated them to pSB1C3 backbone with a ratio of 1:3. Then, we’ve |
− | + | transformed the ligations to DH5α competent cells and grew colonies on LB agar plates containing chloramphenicol at a final concentration of 40 µg/ml. After | |
+ | obtaining DH5α colonies, we’ve done colony PCR and considered the results: We’ve come to the conclusion that colony no. 4 from FucO and no. 8 from GSH have | ||
+ | given the best results. | ||
</p> | </p> | ||
<p> | <p> | ||
− | Thus, we’ve done plasmid isolation for basic 1 from the 4th colony and for basic 2 from the 8th colony, followed by PCR to confirm our results. | + | Thus, we’ve done plasmid isolation for basic 1 from the 4th colony and for basic 2 from the 8th colony, followed by a PCR to confirm our results. |
− | + | ||
</p> | </p> | ||
<div class="col-md-6" style="text-align:center"> | <div class="col-md-6" style="text-align:center"> | ||
− | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2018/8/83/T--METU_HS_Ankara--res01.jpg" /> |
<i class="parts-info"> | <i class="parts-info"> | ||
− | Figure 1: | + | Figure 1: Plate image showing FucO basic inserted into DH5α, and our choice was the 4th colony.The medium was LB with Chl 40. |
</i> | </i> | ||
</div> | </div> | ||
− | |||
<div class="col-md-6" style="text-align:center"> | <div class="col-md-6" style="text-align:center"> | ||
− | <img width="700" src="https://static.igem.org/mediawiki/ | + | <img width="700" src="https://static.igem.org/mediawiki/2018/c/c1/T--METU_HS_Ankara--res02.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | Figure 2: | + | Figure 2: Plate image showing basic part 2 (GSH) transformed into DH5α colonies we’ve obtained.The medium was LB with Chl 40. |
− | + | ||
</i> | </i> | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
Line 117: | Line 95: | ||
<p> | <p> | ||
− | + | In the gel image below, the band on the 5th well demonstrates our correctly inserted gene in pSB1C3 backbone. In PCR, we’ve used FucO left and VR primers to | |
− | + | check the orientation of our part in backbone. Expected band length to see was 625 bp and the results were as expected. | |
</p> | </p> | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
− | <img width="700" src="https://static.igem.org/mediawiki/ | + | <img width="700" src="https://static.igem.org/mediawiki/2018/d/d0/T--METU_HS_Ankara--res03.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | Figure | + | Figure 3: Gel image of the PCR confirmation of basic part 1 (FucO) insertion into pSB1C3. |
− | + | ||
</i> | </i> | ||
</div> | </div> | ||
Line 135: | Line 112: | ||
<p> | <p> | ||
− | 10th well in the gel image below, which belongs to the 8th colony from basic 2 (GSH) cloned DH5α, proves our insertion and transformation right. We’ve used GSH specific primers in PCR and expected to see a band of 225 bp. | + | 10th well in the gel image below, which belongs to the 8th colony from basic 2 (GSH) cloned DH5α, proves our insertion and transformation right. We’ve used |
− | + | GSH specific primers in PCR and expected to see a band of 225 bp. | |
</p> | </p> | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
− | <img width="700" src="https://static.igem.org/mediawiki/ | + | <img width="700" src="https://static.igem.org/mediawiki/2018/6/6e/T--METU_HS_Ankara--bparts04.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | + | Figure 4: Gel image of the PCR confirmation of basic part 2 (GSH) insertion into pSB1C3. | |
− | + | ||
</i> | </i> | ||
</div> | </div> | ||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
− | |||
− | |||
<p> | <p> | ||
− | In order to be able to grow colonies of DH5α with our first, second and third composite parts; we’ve initially ligated the parts to pSB1C3 backbone. | + | In order to be able to grow colonies of DH5α with our first, second and third composite parts; we’ve initially ligated the parts to pSB1C3 backbone. |
− | + | composite part 1’s insert to vector ratio was 1:3, composite 2’s was 1:2 and composite 3’s (Bio-E) was 1:1,5. After that, we’ve transformed the ligations | |
+ | to DH5α competent cells and grew the colonies on LB agar plates containing chloramphenicol at a final concentration of 40 µg/ml. After obtaining DH5α colonies, | ||
+ | we’ve done colony PCR and considering the results that we obtained, we’ve decided the best outcomes were from the 3rd colony from composite 1, 6th colony from | ||
+ | composite 2 and 3rd from composite 3. | ||
</p> | </p> | ||
<div class="col-md-4"> | <div class="col-md-4"> | ||
− | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2018/c/c4/T--METU_HS_Ankara--res05.jpg" /> |
<i class="parts-info"> | <i class="parts-info"> | ||
− | Figure | + | Figure 5: Plate image showing composite part 1 (FucO) transformed DH5α. The medium was LB with Chl 40. |
</i> | </i> | ||
</div> | </div> | ||
<div class="col-md-4"> | <div class="col-md-4"> | ||
− | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2018/1/18/T--METU_HS_Ankara--res06.jpg" /> |
<i class="parts-info"> | <i class="parts-info"> | ||
− | + | Figure 6: Plate image showing composite part 2 (GSH) transformed DH5α. The medium was LB with Chl 40. | |
− | + | ||
− | + | ||
− | + | ||
</i> | </i> | ||
</div> | </div> | ||
<div class="col-md-4"> | <div class="col-md-4"> | ||
− | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2018/e/e6/T--METU_HS_Ankara--res07.jpg" /> |
<i class="parts-info"> | <i class="parts-info"> | ||
− | Figure | + | Figure 7: Plate image showing composite part 3 (GSH & FucO) transformed DH5α. The medium was LB with Chl 40. |
− | + | ||
</i> | </i> | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
Line 197: | Line 160: | ||
<p> | <p> | ||
− | + | The gel image below belongs to the PCR confirmation of FucO composite part insertion. After plasmid isolation, the PCR we’ve conducted with FucO left and | |
− | + | VR primers, using the plasmid as template, was to check orientation of our part in backbone. The expected band length was 754 bp, we decided that 6th and | |
+ | 7th wells confirm our transformation. | ||
</p> | </p> | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
− | <img width="700" src="https://static.igem.org/mediawiki/ | + | <img width="700" src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | + | Figure 8: Gel image of the PCR confirmation of composite part 1 (FucO) insertion into pSB1C3 | |
</i> | </i> | ||
</div> | </div> | ||
Line 214: | Line 178: | ||
<p> | <p> | ||
− | + | We’ve conducted a colony PCR with GSH specific primers to test our transformations of composite part 2 in DH5α. We wanted to see a band of 225 bp on gel | |
− | + | and all GSH colonies have given the band as expected. Below, wells from 11 to 17 confirm our transformations were successful and the 6th colony has given | |
+ | the best result. | ||
</p> | </p> | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
− | <img width="700" src="https://static.igem.org/mediawiki/ | + | <img width="700" src="https://static.igem.org/mediawiki/2018/9/9d/T--METU_HS_Ankara--cparts01256eeie6.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | Figure | + | Figure 9: Gel image of the PCR confirmation of composite part 2 (GSH) insertion into pSB1C3. |
</i> | </i> | ||
</div> | </div> | ||
Line 231: | Line 196: | ||
<p> | <p> | ||
− | + | Our composite part 3, which makes up Bio-E, has the genes both FucO and GSH as coding regions and was successfully inserted in the pSB1C3 backbone. After | |
− | Our composite part 3 has the genes both FucO and GSH as coding regions and was successfully inserted in the pSB1C3 backbone. After transforming the plasmid to DH5α competent cells, we’ve conducted the | + | transforming the plasmid to DH5α competent cells, we’ve conducted the PCR with FucO specific primers and our expected band length for confirmation was 194 bp. |
− | + | All the results seen on the gel (wells 3-11) were positive, proving that our clonings were successful and we have come to the conclusion that the best band | |
+ | was shown by the 3rd colony. | ||
</p> | </p> | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
− | <img width="700" src="https://static.igem.org/mediawiki/ | + | <img width="700" src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | Figure | + | Figure 10: Gel image of the PCR confirmation of composite part 3 (dual expression of FucO and GSH) insertion into pSB1C3. |
− | + | ||
− | + | ||
</i> | </i> | ||
</div> | </div> | ||
Line 248: | Line 212: | ||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
− | <h3> | + | <h3>KO11 Clonings:</h3> |
<p> | <p> | ||
− | In our biochemical assays, our aim was to see the effects of our parts on ethanol production, cell growth, and | + | In our biochemical assays, our aim was to see the effects of our parts on ethanol production, cell growth, and life span using E. coli ethanologenic strain KO11. |
− | + | Since KO11 itself had chloramphenicol resistance in its genome, we had to create a distinction by adding another antibiotic resistance. Thus, we inserted our composite | |
+ | parts to pSB1A3 backbone (carrying Ampicillin resistance) as well and did the transformations to KO11. | ||
</p> | </p> | ||
<p> | <p> | ||
− | + | First composite part’s insert to vector ratio was 1:3, second part’s was 1:2, and the third part’s was 1:1,5. After that, we’ve transformed the ligations to KO11 | |
− | + | competent cells and grew the colonies on LB agar plates containing chloramphenicol at a final concentration of 150 µg/ml and ampicillin at a final concentration of | |
+ | 100 µg/ml. After obtaining KO11 colonies, we’ve done colony PCR and in the end, we recultured the best result giving colonies for plasmid isolation. Chosen colonies | ||
+ | were the 3rd colony for both composite part 1 and 2; and the 2nd colony for composite part 3. | ||
</p> | </p> | ||
<div class="col-md-6" style="text-align:center"> | <div class="col-md-6" style="text-align:center"> | ||
− | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2018/1/1a/T--METU_HS_Ankara--res11.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | + | Figure 11: Plate image showing composite part 1 (FucO) and composite part 2 (GSH) transformed into KO11. The medium was LB with Chl 150 and Amp 100. | |
</i> | </i> | ||
</div> | </div> | ||
<div class="col-md-6" style="text-align:center"> | <div class="col-md-6" style="text-align:center"> | ||
− | <img src="https://static.igem.org/mediawiki/ | + | <img src="https://static.igem.org/mediawiki/2018/f/f2/T--METU_HS_Ankara--res12.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | Figure | + | Figure 12: Plate image showing composite part 3 (FucO and GSH together) transformed into KO11.The medium was LB with Chl 150 and Amp 100. |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</i> | </i> | ||
</div> | </div> | ||
Line 289: | Line 245: | ||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
− | <h3>Composite part 1 (FucO) in pSB1A3 PCR Confirmation | + | <h3>Composite part 1 (FucO) in pSB1A3 PCR Confirmation:</h3> |
<p> | <p> | ||
− | After plasmid isolation, PCR with FucO left and VR primers was conducted to check the orientation of our composite part 1 to pSB1A3 backbone, and the expected band length for that confirmation was 754 bp | + | After plasmid isolation, PCR with FucO left and VR primers was conducted to check the orientation of our composite part 1 to pSB1A3 backbone, and the expected band |
− | + | length for that confirmation was 754 bp. 8th well in the image below (obtained from the plasmid isolation of the 3rd colony) confirms the orientation. | |
</p> | </p> | ||
− | |||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
− | <img width="700" src="https://static.igem.org/mediawiki/ | + | <img width="700" src="https://static.igem.org/mediawiki/2018/f/f1/T--METU_HS_Ankara--cparts07.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | Figure | + | Figure 13: Gel image of the PCR confirmation of composite part 1 (FucO) insertion into pSB1A3. |
</i> | </i> | ||
</div> | </div> | ||
Line 310: | Line 265: | ||
<p> | <p> | ||
− | + | We’ve conducted colony PCR with GSH specific primers for our composite part 2 in pSB1A3 backbone. We wanted to see a band of 225 bp on gel and GSH colonies | |
− | + | 3, 4 & 5 have given the bands as expected. Below; wells 5, 6 and 7 confirm our transformation and we choose to proceed to the plasmid isolation with the colony number 3. | |
</p> | </p> | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
− | <img width="700" src="https://static.igem.org/mediawiki/ | + | <img width="700" src="https://static.igem.org/mediawiki/2018/0/00/T--METU_HS_Ankara--res14.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | + | Figure 14: Gel image of the PCR confirmation of composite part 2 (GSH) insertion into pSB1A3. | |
</i> | </i> | ||
</div> | </div> | ||
Line 324: | Line 279: | ||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
− | <h3>Composite part 3 (FucO & GSH) in pSB1A3 PCR Confirmation:</h3> | + | <h3>Composite part 3 (FucO&GSH) in pSB1A3 PCR Confirmation:</h3> |
<p> | <p> | ||
− | After successfully inserting our composite part 3 (FucO and GSH together) into the pSB1A3 backbone, we’ve done colony PCR with FucO specific primers | + | After successfully inserting our composite part 3 (FucO and GSH together) into the pSB1A3 backbone, we’ve done colony PCR with FucO specific primers. Our expected |
− | + | band length for confirmation was 194 bp and all the results came out positive (seen in wells 12-20), confirming our transformation. Since the best result was seen | |
+ | on colony number 2, we’ve done the plasmid isolation from that colony. | ||
</p> | </p> | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
− | <img width="700" src="https://static.igem.org/mediawiki/ | + | <img width="700" src="https://static.igem.org/mediawiki/2018/4/45/T--METU_HS_Ankara--res10.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | + | Figure 15: Gel image of the PCR confirmation of composite part 3 (dual expression of FucO and GSH) into pSB1A3. | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
</i> | </i> | ||
</div> | </div> | ||
Line 345: | Line 297: | ||
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
− | <h3>Biochemical | + | <h3>Biochemical Assay</h3> |
<p> | <p> | ||
− | We designed our biochemical | + | We designed our biochemical assay in order to evaluate the effects of our circuits on life span, cell mass, and ultimately the bioethanol yield of ethanologenic |
− | + | E. coli strain KO11. We carried out two experimental test sets (1. set: 10mM furfural addition; 2. set: 20mM furfural addition) simultaneously. | |
</p> | </p> | ||
<p> | <p> | ||
− | + | In our biochemical assay, we had four KO11 ethanologenic strains of E.coli cultured groups to test. | |
− | + | ||
</p> | </p> | ||
Line 362: | Line 313: | ||
#2 KO11 with only FucO<br> | #2 KO11 with only FucO<br> | ||
#3 KO11 with only GSH<br> | #3 KO11 with only GSH<br> | ||
− | #4 KO11 with Bio-E | + | #4 KO11 with Bio-E |
</p> | </p> | ||
− | <h3> | + | <h3>Assay #1</h3> |
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
− | <img src=" | + | <img src="https://static.igem.org/mediawiki/2018/9/90/T--METU_HS_Ankara--assay01.jpg" /> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | + | Figure 16: Representation of our biochemical assay #1 | |
</i> | </i> | ||
</div> | </div> | ||
<p> | <p> | ||
− | + | Throughout our first assay, each group was grown in LB mediums containing 2% glucose and antibiotics. | |
− | + | ||
</p> | </p> | ||
<p> | <p> | ||
− | + | To culture group #1 (KO11 un-engineered), we only added Chloramphenicol at a final concentration of 40µg/mL since it only had resistance to Chloramphenicol | |
− | + | in its genome; and to the mediums of the groups numbered 2, 3 and 4, we added Chloramphenicol at a final concentration of 40µg/ml and 100µg/ml Ampicillin. | |
+ | The reason was; groups 2, 3 and 4 had plasmids which carried Ampicillin resistance due to their backbone (pSB1A3). Thus, with the addition of antibiotics | ||
+ | to the mediums, selectivity was assured. | ||
</p> | </p> | ||
<p> | <p> | ||
− | Cultures were grown overnight, and refreshed in the morning | + | Cultures were grown overnight, and refreshed in the morning. After approximately two hours of incubation, furfural was added to the mediums. |
− | + | ||
</p> | </p> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<p> | <p> | ||
− | We added furfural at a final concentration of 10 mM to the | + | We added furfural at a final concentration of 10 mM to the four test groups’ mediums in our first set and took OD measurements at Abs 600 nm with 1/10 |
− | + | dilution in 24 hour time intervals. | |
− | + | ||
</p> | </p> | ||
<p> | <p> | ||
− | 10 mM furfural OD measurements: Abs 600 nm (1/10 dilution) | + | 10 mM furfural OD measurements: Abs 600 nm (1/10 dilution) |
− | + | ||
</p> | </p> | ||
Line 449: | Line 386: | ||
<div class="col-md-12" style="text-align:center"> | <div class="col-md-12" style="text-align:center"> | ||
− | <img style="width: 70%; height: 70%;"src="https://static.igem.org/mediawiki/parts/ | + | <img style="width: 70%; height: 70%;"src="https://static.igem.org/mediawiki/parts/c/c2/METU_HS_Ankara_biochemical_assay_results.jpg"> |
<div style="clear:both"></div> | <div style="clear:both"></div> | ||
<i class="parts-info"> | <i class="parts-info"> | ||
− | + | Figure 17: Graph showing cell growth of assay groups with respect to time. | |
− | + | ||
</i> | </i> | ||
</div> | </div> | ||
− | |||
<h3>Analysis of data:</h3> | <h3>Analysis of data:</h3> | ||
<p> | <p> | ||
− | + | Our data demonstrated that group #1 had a decrease in cell mass throughout the time verifying the inhibition of cell growth in the presence of | |
+ | furfural in the field. Group #2 (KO11 with only FucO) obviously gave better results with respect to un-engineered KO11. However, although the KO11 | ||
+ | group with only FucO showed durability and stability in the first 48 hours, it also experienced depletion in cell mass after the 48th hour. This | ||
+ | proves that only the presence of the gene FucO in the bacteria weren’t enough avoid cell mass depletion in the long term and is in need of another | ||
+ | gene for increased tolerance. Group #4 (KO11 with both FucO and GSH) gave measurement results as we hypothesized by continuing cellular growth in | ||
+ | the first 48 hours and maintaining it even after the 48th hour, though at a lower rate. Overall, we can infer that our best part design (Bio-E) was | ||
+ | successful enough to battle with the inhibitive effects of furfural. | ||
</p> | </p> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
<p> | <p> | ||
− | + | To gather more information to prove our hypothesis, we designed our second experimental set and added furfural at a final concentration of 20mM to | |
− | + | the four test groups’ mediums followed by OD measurements at Abs 600 nm with 1/10 dilution in 24 hour time intervals. | |
</p> | </p> | ||
<p> | <p> | ||
20 mM furfural OD measurements: Abs 600 (1/10 dilution) | 20 mM furfural OD measurements: Abs 600 (1/10 dilution) | ||
− | |||
</p> | </p> | ||
Line 495: | Line 420: | ||
<td>24hrs</td> | <td>24hrs</td> | ||
<td>48hrs</td> | <td>48hrs</td> | ||
+ | <td>72hrs</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 500: | Line 426: | ||
<td>0.67</td> | <td>0.67</td> | ||
<td>0.54</td> | <td>0.54</td> | ||
− | + | <td>0.60</td> | |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 506: | Line 432: | ||
<td>0.54</td> | <td>0.54</td> | ||
<td>0.43</td> | <td>0.43</td> | ||
+ | <td>0.61</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 511: | Line 438: | ||
<td>0.61</td> | <td>0.61</td> | ||
<td>0.60</td> | <td>0.60</td> | ||
+ | <td>0.58</td> | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 516: | Line 444: | ||
<td>0.29</td> | <td>0.29</td> | ||
<td>0.55</td> | <td>0.55</td> | ||
+ | <td></td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
Revision as of 11:32, 17 October 2018